Thyroid Nodules and Cancers Flashcards

1
Q

What are possible causes of thyroid nodules?

A

adenoma (+/-functioning- often benign), cysts, colloid nodule, abscess, granulomatous dz (TB), developmental abnormalities, carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How common are nodules?

A

on PE: 6.4% females and 1.5% in males

up to 37-57% as reported on autopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the steps in evaluation of a thyroid nodule?

A
  1. TSH level - is the nodule causing elevation in TH
  2. FNA can be used to look at the cellularity of a nodule
  3. Thyroid scan (if THS is low and FNA shoes follicular neoplasia) can be used to detect cold, warm, hot (rarely malignant) nodules
  4. thyroid U/S can be useful for sizing nodule and for guiding FNA (cysts are unlikely to be malignant)
  5. I-131 uptake is used additionally in high TSH to differentiate etiology of hyperthryoidism (never in pregnant patients)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What symptoms would raise suspicion for cancer?

A
rapid growth
hard or fixed masses
hoarseness
hx or childhood head/neck radiation
Fhx of thyroid cancer
lymphadenopathy/ distant metastases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is characteristic of a malignant mass that you would want to biopsy?

A
nodules >1cm
solid, hypo echoic lesions
irregular borders
central blood flow 
absence of a halo
hx of radiation exposure
FH of PTC, MTC or MEN
nonfunctioning nodules in the setting of Grave's disease
at risk age groups (70)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 4 types of thyroid cancer discussed in the module?

A
papillary
follicular
anaplastic
medullary
(metastatic cancer and lymphoma are also possible but not common)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the histologic presentation of multi-nodular goiter.

A

enlarged thyroid with nodules separated by thin fibrous bands, variation in follicular size within the nodule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the histologic features of a papillary thyroid carcinoma.

A
papillary architecture
hypercellularity
overlapping nuclei
cleaved or grooved nuclei (coffee bean appearing
nuclear clearing (orphan Annie eyes)
intranuclear cytoplasmic inclusions
prominent nucleoli
psammoma bodies (calcifications at tips of papillary necrosis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Contrast diagnostic testing for papillary cancer v. follicular cancer.

A

papillary cancer only requires FNA for diagnosis because of its defining cytologic features
follicular adenoma/carcinoma requires biopsy that preserves tissue architecture to make the diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the pathologic/histologic features of follicular carcinoma.

A

may or may not have cytologic atypia (more common at the periphery) but will usually have small follicles within a **thick fibrous capsule, for the diagnosis you must have capsular or vascular invasion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the histology of an anapestic carcinoma.

A

sheets of cells with marked pleomorphism, numerous (often abnormal) mitoses, necrosis (may have foci of more well differentiated thyroid carcinoma)— mostly high grade and mostly ugly, often expands rapidly on PE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the histologic features of a medullary carcinoma (proliferation of C-cells)?

A

monotonous cells or infiltrative nest of cells which can be plasmacytoid (eccentric nucleus) or spindle shaped; round/oval nuclei with salt & pepper chromatin, amyloid deposition (congo red stain); proliferation shown with calcitonin immunolabeling (arises from C-cell or parafollicular cells

can be associated with c-cell hyperplasia foci (not specific to medullary carcinoma), can be dx with FNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What treatment is recommended for papillary thyroid v. follicular carcinoma cancer?

A

papillary: excellent prognosis, typically treated with thyroidectomy, and with more aggressive tumors, I-131 and T4 suppression can be added most commonly contains a BRAF mutation and can metastasize to lymphatics, increased risk with neck irradiation
follicular: prognosis is generally good but depends on the extent of extra thyroidal extension and vascular invasion, it metastasizes hematogenously (Hurtle cell may be more aggressive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are poor prognostic features of a papillary thyroid cancer?

A
tumor size >4cm
extra thyroidal extension
vascular invasion
multifocal tumor
bilateral lymph nod metastases
Age > 45
tall cell variant, BRAF mutation  (MAP kinase pathway)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the general prognosis and treatments used in medullary carcinoma?

A

prognosis varies depending on the extent of the disease at diagnosis, the tumor tends to metastasize early (before palpable exam), common in familial forms (prophylactic thyroidectomy in familial forms with RET screening)

treated with thyroidectomy and followed with calcitonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the elements of MEN2a?

A

100% medullary CA of the thyroid
50% pheochromocytoma (bilateral)
parathyroid hyperplasia/adenoma

due to gain of function of the RET oncogene

17
Q

What are the features of MEN2b?

A

100% medullary CA thyroid
50% pheochromocytoma

due to gain of function of the RET oncogene
marfaniod habits, mucosal neuromas and poor prognosis

18
Q

Contrast the tumor markers used in papillary v. medullary cancers.

A

papillary and follicular- thryogoblulin

medullary: calcitonin

19
Q

What are the features of MEN 1?

A

PPP
parathyroid hyperplasia
pancreatic neuroendocrine tumors
pituitary tumors

Other: entero-pancratitc tumors, adrenal tumors

due to loss of function of a tumor suppressor